Skip to content

Hamilton Lane HLNE Acquired in-process research and development

Acquired in-process research and development at other companies

ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$684.75K
Erasca, Inc. logo
Erasca, Inc.ERAS
$150M
Mid-America Apartment Communities logo
Mid-America Apartment CommunitiesMAA
$75.26M+13.6%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$6.97M+133%
Hamilton Lane logo
Hamilton LaneHLNE
$0-100%
Cboe Global Markets logo
Cboe Global MarketsCBOE
$0-100%

Other financials

Income statement

See full
Revenue$193.6M-2.2%
Net income$66.2M+31.0%
EPS (diluted)$1.48+9.4%

Balance sheet

See full
Cash & equivalents$348.0M+6.3%
Total debt$356.5M-3.2%
Total equity$915.2M+27.6%
Total assets$2.3B+36.4%

Cash flow

See full
Operating cash flow$103.0M+162%
CapEx$1.7M-49.3%
Free cash flow$101.2M+182%

Valuation

See full
Market cap$3.3B-32.2%

Profitability

See full
Net margin32.8%+2.3pp
FCF margin55.2%+14.7pp

Returns & leverage

See full
Return on equity30.5%-4.5pp
Debt / equity0.4×-0.1×

Where this comes from

Reported directly by Hamilton Lane in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfIntangibleAssets.

The official record: Hamilton Lane’s 10-K, filed May 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hamilton Lane's acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Hamilton Lane's acquired in-process research and development?
Hamilton Lane (HLNE) reported acquired in-process research and development of $0 in Q1 2026.
How has Hamilton Lane's acquired in-process research and development changed year-over-year?
Hamilton Lane's acquired in-process research and development decreased by 100.0% year-over-year, from $292K to $0.
What does acquired in-process research and development mean?
Represents the cash consideration paid to acquire research and development projects that have not yet reached technological feasibility or regulatory approval. This metric is a proxy for the company's investment in future innovation and long-term growth through external acquisition. It highlights the capital intensity of the company's R&D strategy.